358 related articles for article (PubMed ID: 21989653)
1. Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia.
Baldini M; Maugeri N; Ramirez GA; Giacomassi C; Castiglioni A; Prieto-González S; Corbera-Bellalta M; Di Comite G; Papa I; Dell'antonio G; Ammirati E; Cuccovillo I; Vecchio V; Mantovani A; Rovere-Querini P; Sabbadini MG; Cid MC; Manfredi AA
Arthritis Rheum; 2012 Mar; 64(3):854-65. PubMed ID: 21989653
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of the endothelin system in arterial lesions from patients with giant-cell arteritis: association between elevated plasma endothelin levels and the development of ischaemic events.
Lozano E; Segarra M; Corbera-Bellalta M; García-Martínez A; Espígol-Frigolé G; Plà-Campo A; Hernández-Rodríguez J; Cid MC
Ann Rheum Dis; 2010 Feb; 69(2):434-42. PubMed ID: 19289383
[TBL] [Abstract][Full Text] [Related]
3. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism.
Hernández-Rodríguez J; Segarra M; Vilardell C; Sánchez M; García-Martínez A; Esteban MJ; Grau JM; Urbano-Márquez A; Colomer D; Kleinman HK; Cid MC
Circulation; 2003 May; 107(19):2428-34. PubMed ID: 12742994
[TBL] [Abstract][Full Text] [Related]
4. Arterial wall production of cytokines in giant cell arteritis: results of a pilot study using human temporal artery cultures.
Blain H; Abdelmouttaleb I; Belmin J; Blain A; Floquet J; Guéant JL; Jeandel C
J Gerontol A Biol Sci Med Sci; 2002 Apr; 57(4):M241-5. PubMed ID: 11909890
[TBL] [Abstract][Full Text] [Related]
5. Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis.
Corbera-Bellalta M; García-Martínez A; Lozano E; Planas-Rigol E; Tavera-Bahillo I; Alba MA; Prieto-González S; Butjosa M; Espígol-Frigolé G; Hernández-Rodríguez J; Fernández PL; Roux-Lombard P; Dayer JM; Rahman MU; Cid MC
Ann Rheum Dis; 2014 Mar; 73(3):616-23. PubMed ID: 23625984
[TBL] [Abstract][Full Text] [Related]
6. IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis.
Ciccia F; Alessandro R; Rizzo A; Raimondo S; Giardina A; Raiata F; Boiardi L; Cavazza A; Guggino G; De Leo G; Salvarani C; Triolo G
Ann Rheum Dis; 2013 Feb; 72(2):258-64. PubMed ID: 22872024
[TBL] [Abstract][Full Text] [Related]
7. Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis.
Tombetti E; Di Chio MC; Sartorelli S; Papa M; Salerno A; Bottazzi B; Bozzolo EP; Greco M; Rovere-Querini P; Baldissera E; Del Maschio A; Mantovani A; De Cobelli F; Sabbadini MG; Manfredi AA
Arthritis Res Ther; 2014 Nov; 16(6):479. PubMed ID: 25394473
[TBL] [Abstract][Full Text] [Related]
8. Limited utility of novel serological biomarkers in patients newly suspected of having giant cell arteritis.
Sammel AM; Xue M; Karsten E; Little CB; Smith S; Nguyen K; Laurent R
Int J Rheum Dis; 2021 Jun; 24(6):781-788. PubMed ID: 33847438
[TBL] [Abstract][Full Text] [Related]
9. Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis.
Corbera-Bellalta M; Planas-Rigol E; Lozano E; Terrades-García N; Alba MA; Prieto-González S; García-Martínez A; Albero R; Enjuanes A; Espígol-Frigolé G; Hernández-Rodríguez J; Roux-Lombard P; Ferlin WG; Dayer JM; Kosco-Vilbois MH; Cid MC
Ann Rheum Dis; 2016 Jun; 75(6):1177-86. PubMed ID: 26698852
[TBL] [Abstract][Full Text] [Related]
10. PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases.
Ramirez GA; Rovere-Querini P; Blasi M; Sartorelli S; Di Chio MC; Baldini M; De Lorenzo R; Bozzolo EP; Leone R; Mantovani A; Manfredi AA; Tombetti E
Front Immunol; 2019; 10():1135. PubMed ID: 31191526
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis.
Terrier B; Geri G; Chaara W; Allenbach Y; Rosenzwajg M; Costedoat-Chalumeau N; Fouret P; Musset L; Benveniste O; Six A; Klatzmann D; Saadoun D; Cacoub P
Arthritis Rheum; 2012 Jun; 64(6):2001-11. PubMed ID: 22147555
[TBL] [Abstract][Full Text] [Related]
12. Neurotrophins are expressed in giant cell arteritis lesions and may contribute to vascular remodeling.
Ly KH; Régent A; Molina E; Saada S; Sindou P; Le-Jeunne C; Brézin A; Witko-Sarsat V; Labrousse F; Robert PY; Bertin P; Bourges JL; Fauchais AL; Vidal E; Mouthon L; Jauberteau MO
Arthritis Res Ther; 2014 Nov; 16(6):487. PubMed ID: 25418464
[TBL] [Abstract][Full Text] [Related]
13. Giant cell arteritis presenting as bilateral anterior ischemic optic neuropathy: a biopsy-proven case report in Chinese patient.
Tian G; Chen W; Chen Q; Wang M; Zhao G; Li Z; Zhang J
BMC Ophthalmol; 2018 Oct; 18(1):282. PubMed ID: 30376812
[TBL] [Abstract][Full Text] [Related]
14. Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis.
Espígol-Frigolé G; Corbera-Bellalta M; Planas-Rigol E; Lozano E; Segarra M; García-Martínez A; Prieto-González S; Hernández-Rodríguez J; Grau JM; Rahman MU; Cid MC
Ann Rheum Dis; 2013 Sep; 72(9):1481-7. PubMed ID: 22993227
[TBL] [Abstract][Full Text] [Related]
15. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis.
Rueda B; Lopez-Nevot MA; Lopez-Diaz MJ; Garcia-Porrua C; Martín J; Gonzalez-Gay MA
J Rheumatol; 2005 Sep; 32(9):1737-41. PubMed ID: 16142870
[TBL] [Abstract][Full Text] [Related]
16. Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes.
Alles VV; Bottazzi B; Peri G; Golay J; Introna M; Mantovani A
Blood; 1994 Nov; 84(10):3483-93. PubMed ID: 7949102
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptors in giant cell arteritis. An immunocytochemical, western blot and RT-PCR study.
Petursdottir V; Nordborg E; Moraghebi N; Persson M; Nordborg C
Clin Exp Rheumatol; 1999; 17(6):671-7. PubMed ID: 10609065
[TBL] [Abstract][Full Text] [Related]
18. A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL-40/Interleukin-13 Receptor α2 Axis.
van Sleen Y; Jiemy WF; Pringle S; van der Geest KSM; Abdulahad WH; Sandovici M; Brouwer E; Heeringa P; Boots AMH
Arthritis Rheumatol; 2021 Dec; 73(12):2327-2337. PubMed ID: 34105308
[TBL] [Abstract][Full Text] [Related]
19. Anterior ischemic optic neuropathy due to giant cell arteritis with normal inflammatory markers.
Yoeruek E; Szurman P; Tatar O; Weckerle P; Wilhelm H
Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):913-5. PubMed ID: 18386041
[TBL] [Abstract][Full Text] [Related]
20. NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica.
Dejaco C; Duftner C; Al-Massad J; Wagner AD; Park JK; Fessler J; Aigelsreiter A; Hafner F; Vega S; Sterlacci W; Grubeck-Loebenstein B; Tzankov A; Ness T; Boiardi L; Salvarani C; Schirmer M
Ann Rheum Dis; 2013 Nov; 72(11):1852-9. PubMed ID: 23417963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
